EUVIMEDEUVIMED entdecken
Multizentrische Studie

Singapore’s experience on the VasQ™ anastomotic external support device to augment arteriovenous fistula maturation: Real world outcomes

Xuxin Lim iD, Li Zhang, Ying Pan, Qiantai Hong iD, Malcolm Mak, Lester Rhan Chaen Chong iD, Shufen Neo, Glenn Wei Leong Tan iD, Rajesh Babu Dharmaraj, Jun Jie Ng iD, Shao Wei Chong, Pei Ho iD und 1 weitere

The Journal of Vascular Access · 2026

DOI: 10.1177/11297298251377946 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift The Journal of Vascular Access, 2026. Verfasst von Xuxin Lim und 12 weiteren Autor:innen. Beteiligte Einrichtung: Vascular Surgery Service, Department of General Surgery, Tan Tock Seng Hospital, Singapore. Hauptthemen laut MEDLINE: Arteriovenous Shunt, Surgical, Renal Dialysis, Upper Extremity, Blood Vessel Prosthesis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 29 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

The VasQ™ anastomotic external support device is designed to facilitate maturation and usability of AVFs. This study reports the initial experience of VasQ usage across two centers in Singapore.

Methods

This is a review of 118 consecutive patients who had the VasQ™ device implanted during surgical AVF creation from October 2023 to February 2025 at two tertiary referral centers in Singapore.

Results

Out of the 118 AVFs created with the VasQ™ device, 57.6% were radiocephalic (RC) fistulas, 33.9% were brachiocephalic (BC) fistulas and 8.4% were brachiobasilic transposition (BVT) fistulas. The most common VasQ™ device size used in our population was size 4 (45.8%) followed by size 3 (29.7%). AVF physiological maturation was 64.4%, 83.1%, and 95.8% at 1, 3, and 6 months respectively. The overall balloon-assisted maturation (BAM) rate in our cohort of patients was 26.9%. There were 4 (3.9%) instances of hemodialysis access induced distal ischemia. There were no device related complications nor infections during the follow-up period. Primary patency was 62.5%, 49.0%, and 37.3% at 6, 12, and 18 months respectively. Secondary patency was 98.3%, 88.4%, and 86.2% at 6, 12, and 18 months respectively. Comparatively, previous retrospective series in our center demonstrated a primary failure rate of 25% with RC AVFs and primary patency rates of 33% and secondary patency rates of 72% at 12 months without the use of VasQ™ device.

Conclusion

The VasQ™ device demonstrated safety and efficacy with improved AVF maturation in a real-world Asian population, across all AVF types (RC, BC, and BVT). The rate of primary failure was low while the BAM rate has improved compared to our historical data. We recommend the use of VasQ™ device as standard of care in patients undergoing AVF creation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Arteriovenous Shunt, SurgicalRenal DialysisUpper ExtremityBlood Vessel ProsthesisBlood Vessel Prosthesis ImplantationHumansSingaporeVascular PatencyMaleFemaleTreatment OutcomeMiddle AgedRetrospective StudiesTime FactorsAgedProsthesis DesignGraft Occlusion, VascularAdultRisk FactorsAged, 80 and over

Stichwörter der Autor:innen

Arteriovenous fistulaVasQ™cannulationmaturationpatency

Autor:innen und Institutionen

  • Vascular Surgery Service, Department of General Surgery, Tan Tock Seng Hospital, Singapore.
  • Department of Paediatric Surgery, KK Women's and Children's Hospital, Singapore.
  • Department of Cardiac, Thoracic and Vascular Surgery, National University Hospital, Singapore.

ORCID-Profile: Xuxin Lim, Qiantai Hong, Lester Rhan Chaen Chong, Glenn Wei Leong Tan, Jun Jie Ng, Pei Ho, Enming Yong

Zitieren

APA

Lim, X., Zhang, L., Pan, Y., Hong, Q., Mak, M., Chong, L. R. C., Neo, S., Tan, G. W. L., Dharmaraj, R. B., Ng, J. J., Chong, S. W., Ho, P., & Yong, E. (2026). Singapore’s experience on the VasQ™ anastomotic external support device to augment arteriovenous fistula maturation: Real world outcomes. The Journal of Vascular Access. https://doi.org/10.1177/11297298251377946

Vancouver

Lim X, Zhang L, Pan Y, Hong Q, Mak M, Chong LRC, et al. Singapore’s experience on the VasQ™ anastomotic external support device to augment arteriovenous fistula maturation: Real world outcomes. The Journal of Vascular Access. 2026. doi:10.1177/11297298251377946

BibTeX
@article{Lim2026,
  author = {Lim, Xuxin and Zhang, Li and Pan, Ying and Hong, Qiantai and Mak, Malcolm and Chong, Lester Rhan Chaen and Neo, Shufen and Tan, Glenn Wei Leong and Dharmaraj, Rajesh Babu and Ng, Jun Jie and Chong, Shao Wei and Ho, Pei and Yong, Enming},
  title = {Singapore’s experience on the VasQ™ anastomotic external support device to augment arteriovenous fistula maturation: Real world outcomes},
  journal = {The Journal of Vascular Access},
  year = {2026},
  doi = {10.1177/11297298251377946}
}
Kostenlos starten →